- Home
- PHGE vs SCNI Comparison
PHGE vs SCNI Comparison
Compare PHGE & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHGE | SCNI |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 1.7M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PHGE | SCNI |
|---|---|---|
| Price | $0.14 | $1.85 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 252.8K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 560.42 | 50.00 |
| EPS | ★ 3.56 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.04 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $0.21 |
| 52 Week High | $8.50 | $3.58 |
Technical Indicators
Market Signals| Indicator | PHGE | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 46.18 | 62.03 |
| Support Level | N/A | $0.40 |
| Resistance Level | $0.21 | $3.58 |
| Average True Range (ATR) | 0.01 | 0.26 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 2.02 | 54.16 |
Price Performance
Historical ComparisonAbout PHGE BiomX Inc. COmmon Stock
BiomX Inc is a company focused on acquiring and further developing technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response sectors. The Company's portfolio is built around the growing need for earlier and more accurate threat detection, particularly as UAVs and other autonomous systems play a larger role in defense and homeland security.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.